Chinese Drug Regulator Puts Sichuan Biokin Pharmaceutical's Naxopharynx Cancer Drug in Breakthrough Drugs List
Chinese Drug Regulator Puts Sichuan Biokin Pharmaceutical's Naxopharynx Cancer Drug in Breakthrough Drugs List
中国药品监管机构将四川博康制药的Naxopharynx抗癌药物列入突破性药物清单
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册